Editorial: Taking a Different Route–Navigating the Switch From Intravenous to Subcutaneous Vedolizumab. Authors' Reply

Marianne Hupé, Xavier Roblin, David Laharie
Alimentary Pharmacology and Therapeutics · Wiley · 2026-10-20 · DOI: 10.1111/apt.71069

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles